Market Place
Sourcing Support
All News #Library
Biotech
Hillstream Advances Next-Gen Multispecific Antibodies with HSB-3215
20 Jul 2023 //
GLOBENEWSWIRE
Hillstream Announces Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors
10 Jul 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 & HER3 ADC
06 Jul 2023 //
GLOBENEWSWIRE
Hillstream Selects OncoBay Clinical to Advance HSB-1216
13 Apr 2023 //
GLOBENEWSWIRE
Hillstream BioPharma Announces Pharmacokinetic Data of HSB-1216
10 Apr 2023 //
GLOBENEWSWIRE
Hillstream Demonstrated Greater Tumor Inhibition Combining Pembrolizumab
10 Feb 2023 //
GLOBENEWSWIRE
Hillstream Announces Acceptance of Abstract at AACR Highlighting HSB-510
08 Feb 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.